Buy AP Photo Reprints

Your Questions Answered Ask AP: Shuttle complexity, credit union agency

HOPKINTON, Mass. (AP) -- Caliper Life Sciences Inc., which makes technologies used for drug development, said Monday its third-quarter loss narrowed on lower costs and charges.

For the period ended Sept. 30, Caliper reported lost $3.4 million, or 7 cents per share, compared with a loss of $5.4 million, or 11 cents per share, in the same period last year. Revenue fell 5 percent to $32.2 million from $34 million.

Meanwhile, costs and expenses fell 9 percent to $35.3 million on lower restructuring charges and research and development costs.

Looking ahead, the company said it expects fourth-quarter revenue between $34.5 million and $36.5 million. It expects full-year revenue between $127 million and $129 million.

Shares of Caliper rose 40 cents, or 19 percent, to $2.55 in afternoon trading. The stock has traded between 63 cents and $3.02 over the last 52 weeks.

© 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy.

Click here for copyright permissions! Copyright 2008 Associated Press